Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, announced that it has […]
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
Oricell Therapeutics, a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, […]
Plugging Immune Cell Leakage from Tumors Could Improve Skin Cancer Treatment
The number of specialized immune cells available for fighting skin cancer doubled when a new […]
Eluminex Biosciences Closes $40+ Million Series B Financing
Eluminex Biosciences has officially announced the closing of a Series B financing of over $40 […]
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced Solutions and Yinjia Biosciences announced a strategic partnership in developing core protein raw […]
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
Oscotec announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of […]
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
AlloVir, a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Derek […]
Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus
Nektar Therapeutics today announced topline data from a Phase 2 randomized, double-blind, placebo-controlled study of […]
Roche launches Two New Antibodies to Identify Key Clinical Mutations in Patients with Brain Cancer
Roche announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and […]
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical
Olympus Corporation, a global MedTech company committed to making people’s lives healthier, safer and more […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more